Pentagon ordered to study menopause gap in military medicine
H.R. 2717 — Servicewomen and Veterans Menopause Research Act · Filed by Chrissy Houlahan (D-PA) · 25 cosponsors · Introduced Apr 8, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Department of Defense and Veterans Affairs to evaluate existing research on menopause and mid-life women's health among servicewomen and female veterans, identify gaps in knowledge (including effects of combat exposure, burn pits, and PFAS), and submit a report with recommendations and a strategic research plan within 180 days. It also expresses Congress's sense that these agencies should conduct additional research on menopause-related treatments and their impact on military women.
Why we flagged it
The bill is a straightforward mandate for federal agencies to evaluate and plan research on a specific health condition affecting a defined population (servicewomen and female veterans). It contains no tax provisions, subsidies, or regulatory carve-outs—only research evaluation and reporting requirements.
What the text implies
- The bill's focus on service-related menopause impacts (burn pits, PFAS, combat roles) may establish a precedent for recognizing menopause-related conditions as service-connected disabilities, potentially expanding VA benefits eligibility.
- Requiring evaluation of 'uptake of treatments' and 'availability' may implicitly pressure DoD and VA to expand access to hormone replacement therapy and other menopause treatments in military healthcare systems.
The full analysis lists 3 implications of this text.
Who it affects
The bill directs federal agencies to study a significant health gap affecting servicewomen and female veterans—menopause and mid-life health—and to improve training for military healthcare providers. This addresses a documented underserving of women's health in military medicine and may lead to better treatment access and understanding of service-related health impacts for this population.